| Name | Title | Contact Details |
|---|---|---|
Veda Walcott |
VP, Quality, Biologics & Global Regulatory Affairs | Profile |
Charles Lickfold |
Senior Vice President and Chief Information Officer | Profile |
Kay Schmidt |
Senior Vice President of Technical Operations | Profile |
Alessandro Maselli |
President and Chief Operating Officer | Profile |
Jody Jenkins |
CISO | Profile |
Development Centers Inc is a Detroit, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Mena Regional Health System is a Mena, AR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BMC Communications Group is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At PolyNovo we are driven by improving the outcomes of patients through development and provision of the best surgical solutions possible. PolyNovo develops innovative medical devices utilizing the patented bioabsorbable polymer technology Novosorb®. NovoSorb is a family of proprietary medical grade polymers that can be expressed in a variety of physical formats. NovoSorb polymers have advantageous properties such as biocompatibility and design flexibility. These properties underpin novel medical devices designed to support tissue repair, before they biodegrade in situ into biocompatible by-products via established pathways. NovoSorb BTM (Biodegradable Temporizing Matrix) is the first product commercialized by PolyNovo. In 2015, following the FDA 510(K) clearance of BTM, PolyNovo was awarded an $11 million contract and a further $25 million in funding from the US-based Biomedical Advanced Research and Development Authority (BARDA) to complete a trial with BTM for full thickness burns. We have expanded our manufacturing facility and headquarters in Melbourne, Australia, establishing high quality processes, enabling product innovation and preparing for growth.
NovaSom is a Glen Burnie, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.